These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 454559)

  • 1. Peripheral electrophysiological parameters in mice treated with misonidazole.
    Von Burg R; Conroy PJ; Passalacqua W
    Br J Cancer; 1979 Jul; 40(1):134-43. PubMed ID: 454559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroneurographic investigations of misonidazole polyneuropathy.
    Mamoli B; Wessely P; Kogelnik HD; Müller M; Rathkolb O
    Eur Neurol; 1979; 18(6):405-14. PubMed ID: 232682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misonidazole Neuropathy: a clinical, electrophysiological, and histological study.
    Melgaard B; Hansen HS; Kamieniecka Z; Paulson OB; Pedersen AG; Tang X; Trojaborg W
    Ann Neurol; 1982 Jul; 12(1):10-7. PubMed ID: 7114817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice.
    Conroy PJ; Von Burg R; Penney DP; Passalacqua W; Sutherland RM
    Br J Cancer; 1980 Apr; 41(4):523-8. PubMed ID: 7387850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the radiosensitizer misonidazole on motor nerve conduction velocity in the mouse.
    Hirst DG; Vojnovic B; Stratford IJ; Travis EL
    Br J Cancer Suppl; 1978 Jun; 3():237-41. PubMed ID: 277237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misonidazole neurotoxicity in the mouse: evaluation of functional, pharmacokinetic, electrophysiologic and morphologic parameters.
    Conroy PJ; Von Burg R; Passalacqua W; Penney DP; Sutherland RM
    Int J Radiat Oncol Biol Phys; 1979 Jul; 5(7):983-91. PubMed ID: 511631
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in nerve conduction velocity in the mouse after acute and chronic administration of nitroimidazoles.
    Hirst DG; Vojnovic B; Hobson B
    Br J Cancer; 1979 Feb; 39(2):159-67. PubMed ID: 435365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of studying sural nerve conduction and late responses in the evaluation of alcoholic subjects.
    D'Amour ML; Shahani BT; Young RR; Bird KT
    Neurology; 1979 Dec; 29(12):1600-4. PubMed ID: 574223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral neuropathy related to misonidazole: incidence and pathology.
    Urtasun RC; Chapman JD; Feldstein ML; Band RP; Rabin HR; Wilson AF; Marynowski B; Starreveld E; Shnitka T
    Br J Cancer Suppl; 1978 Jun; 3():271-5. PubMed ID: 209809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicity of misonidazole in rats following intravenous administration.
    Graziano MJ; Henck JW; Meierhenry EF; Gough AW
    Pharmacol Res; 1996 Jun; 33(6):307-18. PubMed ID: 8971952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of progesterone on neuropathic pain responses in an experimental animal model for peripheral neuropathy in the rat: a behavioral and electrophysiological study.
    Jarahi M; Sheibani V; Safakhah HA; Torkmandi H; Rashidy-Pour A
    Neuroscience; 2014 Jan; 256():403-11. PubMed ID: 24184116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatosensory deficits in monkeys treated with misonidazole.
    Maurissen JP; Conroy PJ; Passalacqua W; Von Burg R; Weiss B; Sutherland RM
    Toxicol Appl Pharmacol; 1981 Jan; 57(1):119-26. PubMed ID: 7209982
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of misonidazole on some physiologic parameters in mice.
    Conroy PJ; von Burg R; Passalacqua W; Sutherland RM
    J Pharmacol Exp Ther; 1980 Jan; 212(1):47-52. PubMed ID: 7351625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse.
    Clarke C; Dawson KB; Sheldon PW
    Br J Cancer; 1982 Apr; 45(4):582-7. PubMed ID: 7073948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misonidazole neuropathy.
    Paulson OB; Melgaard B; Hansen HS; Kamieniecka Z; Køhler O; Hansen JM; Pedersen AG; Tang X; Trojaborg W
    Acta Neurol Scand Suppl; 1984; 100():133-6. PubMed ID: 6091392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral neuropathy in B6C3F1 mice and SD rats induced by chronic intermittent insulin hypoglycemia.
    Tabata H
    Drug Chem Toxicol; 2000 Aug; 23(3):485-96. PubMed ID: 10959549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxicity of Adriamycin and misonidazole in the mouse.
    Boegman RJ; Scarth B; Dragovic L; Robertson DM
    Exp Neurol; 1985 Jan; 87(1):1-8. PubMed ID: 2981696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subclinical lesions of peripheral nervous system in multiple sclerosis patients].
    Pogorzelski R; Baniukiewicz E; Drozdowski W
    Neurol Neurochir Pol; 2004; 38(4):257-64. PubMed ID: 15383952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DFP-induced elevation of strength-duration threshold in hen peripheral nerve.
    Anderson RJ; Robertson DG; Henderson JD; Wilson BW
    Neurotoxicology; 1988; 9(1):47-52. PubMed ID: 3393302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity.
    Jones DH; Bleehen NM; Workman P; Smith NC
    Br J Radiol; 1983 Nov; 56(671):865-70. PubMed ID: 6626878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.